Active Not RecruitingNCT05407636
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
PHASE3 · 735 planned enrolment
- Countries listed
- 10
- Registry update
- August 3, 2026
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
2 matching trial registrations
- Intervention ABBV-RGX-314 Dose 1
- Topic Vision ageing
Showing 1–2 of 2. Every record below meets all the filters shown above.
Active Not RecruitingNCT04514653
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)
PHASE2 · 146 planned enrolment
- Countries listed
- 1
- Registry update
- February 27, 2026